CWC
Carolinas Wealth Consulting Portfolio holdings
AUM
$465M
This Quarter Return
+8.1%
1 Year Return
+8.53%
3 Year Return
+24.59%
5 Year Return
+125.43%
10 Year Return
–
AUM
$459M
AUM Growth
+$459M
(+6.9%)
Cap. Flow
+$1.34M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
43.51%
Holding
1,040
New
74
Increased
351
Reduced
201
Closed
45
Top Buys
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$1.39M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
$978K |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$858K |
| 4 |
Vanguard Russell 1000 Value ETF
VONV
|
$698K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$692K |
Top Sells
| 1 |
Microsoft
MSFT
|
$4.48M |
| 2 |
Apple
AAPL
|
$1.8M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
$997K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$929K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$840K |
Sector Composition
| 1 | Technology | 7.22% |
| 2 | Financials | 6.35% |
| 3 | Communication Services | 4.29% |
| 4 | Consumer Discretionary | 3.18% |
| 5 | Healthcare | 1.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Starbucks
SBUX
$102B
| $252K | 0.05% |
2,154
+259
| +14% | +$30.3K |
|
152
Union Pacific
UNP
$132B
| $247K | 0.05% |
982
+328
| +50% | +$82.5K |
|
153
Vanguard Short-Term Treasury ETF
VGSH
$22.8B
| $243K | 0.05% |
3,993
-357
| -8% | -$21.7K |
|
154
Vanguard Health Care ETF
VHT
$15.6B
| $243K | 0.05% |
912
-159
| -15% | -$42.4K |
|
155
McDonald's
MCD
$225B
| $240K | 0.05% |
894
+291
| +48% | +$78.1K |
|
156
Blackstone
BX
$132B
| $235K | 0.05% |
1,814
+361
| +25% | +$46.8K |
|
157
ResMed
RMD
$39.7B
| $231K | 0.05% |
888
+200
| +29% | +$52K |
|
158
Pfizer
PFE
$142B
| $230K | 0.05% |
3,902
+366
| +10% | +$21.6K |
|
159
Colgate-Palmolive
CL
$68.2B
| $223K | 0.05% |
2,613
-670
| -20% | -$57.2K |
|
160
Coherent
COHR
$13.7B
| $218K | 0.05% |
3,185
+760
| +31% | +$52K |
|
161
Target
TGT
$42B
| $218K | 0.05% |
944
+48
| +5% | +$11.1K |
|
162
Skechers
SKX
$9.49B
| $217K | 0.05% |
5,000
| – | – |
|
163
Salesforce
CRM
$242B
| $215K | 0.05% |
845
| – | – |
|
164
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$584M
| $214K | 0.05% |
3,980
+1,539
| +63% | +$82.8K |
|
165
Medtronic
MDT
$120B
| $212K | 0.05% |
2,034
-377
| -16% | -$39.3K |
|
166
Vanguard Russell 1000 ETF
VONE
$6.6B
| $206K | 0.04% |
940
| – | – |
|
|
GLO
167
Clough Global Opportunities Fund
GLO
$236M
| $202K | 0.04% |
18,944
| – | – |
|
168
XPeng
XPEV
$19.8B
| $201K | 0.04% |
4,000
| – | – |
|
169
Linde
LIN
$222B
| $200K | 0.04% |
577
+214
| +59% | +$74.2K |
|
170
Invesco Large Cap Growth ETF
PWB
$1.24B
| $200K | 0.04% |
2,474
| – | – |
|
171
Adobe
ADBE
$147B
| $194K | 0.04% |
343
-7
| -2% | -$3.96K |
|
172
HCA Healthcare
HCA
$95B
| $193K | 0.04% |
750
| – | – |
|
173
US Bancorp
USB
$75.5B
| $193K | 0.04% |
3,405
+860
| +34% | +$48.7K |
|
174
SPDR S&P Biotech ETF
XBI
$5.25B
| $192K | 0.04% |
1,714
| – | – |
|
175
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.09B
| $191K | 0.04% |
4,031
+26
| +0.6% | +$1.23K |
|